Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CENTAUR: Cenicriviroc in NASH
NCT02217475Phase 2Completed
- Sponsor
- Tobira Therapeutics
- Start
- Sep 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of cenicriviroc in Nonalcoholic steatohepatitis (NASH), Liver Fibrosis (LF), sponsored by Tobira Therapeutics. Started Sep 2014; status: completed.
02
Drugs
cenicriviroc
03
Conditions
Nonalcoholic steatohepatitis (NASH)Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT02217475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02217475.